Toxic hepatitis case with prolonged jaundice due to Favipiravir

Yolaçan, Ramazan; Karabulut, Ümit; Üzel, Ali; Uçmak, Feyzullah; Kaya, Muhsin

doi:10.14744/hf.2022.2022.0007

Ramazan Yolaçan¹ ,

Ümit Karabulut¹ ,

Ali Üzel¹ ,

Feyzullah Uçmak¹ ,

Muhsin Kaya¹

¹Division of Gastroenterology and Hepatology, Department of Internal Medicine, Dicle University School of Medicine, Diyarbakir, Turkiye

Hepatology Forum 2022; 3(3): 95-96 DOI: 10.14744/hf.2022.2022.0007 PMCID: PMC9510735

Full Text PDF

Abstract

Favipiravir is an antiviral drug used in the treatment of SARS-CoV2 infection. The main side effects of this drug are teratogenicity and hyperuricemia. Limited information is available on other side effects. Here, we aimed to present our toxic hepatitis case with prolonged jaundice after favipiravir treatment.

Keywords: COVID-19; favipiravir; jaundice; toxic hepatitis.